168 related articles for article (PubMed ID: 9467741)
1. Loss of oral infectivity of tissue cysts of Toxoplasma gondii RH strain to outbred Swiss Webster mice.
Villard O; Candolfi E; Ferguson DJ; Marcellin L; Kien T
Int J Parasitol; 1997 Dec; 27(12):1555-9. PubMed ID: 9467741
[TBL] [Abstract][Full Text] [Related]
2. Stage conversion of Toxoplasma gondii RH parasites in mice by treatment with atovaquone and pyrrolidine dithiocarbamate.
Djurković-Djaković O; Nikolić A; Bobić B; Klun I; Aleksić A
Microbes Infect; 2005 Jan; 7(1):49-54. PubMed ID: 15716077
[TBL] [Abstract][Full Text] [Related]
3. Infection and immunity with the RH strain of Toxoplasma gondii in rats and mice.
Dubey JP; Shen SK; Kwok OC; Frenkel JK
J Parasitol; 1999 Aug; 85(4):657-62. PubMed ID: 10461945
[TBL] [Abstract][Full Text] [Related]
4. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.
Ferreira RA; Oliveira AB; Ribeiro MF; Tafuri WL; Vitor RW
Exp Parasitol; 2006 Jun; 113(2):125-9. PubMed ID: 16458300
[TBL] [Abstract][Full Text] [Related]
5. Comparative infectivity of Toxoplasma gondii bradyzoites in rats and mice.
Dubey JP
J Parasitol; 1998 Dec; 84(6):1279-82. PubMed ID: 9920331
[TBL] [Abstract][Full Text] [Related]
6. Comparative Immunological Response and Pathobiology of Mice Inoculated with Toxoplasma gondii Isolated from Different Hosts.
Yang Y; Ren H; Xin S; Jiang N
J Parasitol; 2021 Mar; 107(2):179-181. PubMed ID: 33662116
[TBL] [Abstract][Full Text] [Related]
7. Toxoplasma gondii: in vivo and in vitro cystogenesis of the virulent RH strain.
De Champs C; Imbert-Bernard C; Belmeguenai A; Ricard J; Pelloux H; Brambilla E; Ambroise-Thomas P
J Parasitol; 1997 Feb; 83(1):152-5. PubMed ID: 9057714
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
[TBL] [Abstract][Full Text] [Related]
9. [Antigenic differentiation among 3 life-cycle stages of Toxoplasma gondii using fluorescent antibodies].
Angel JE; Marinkelle CJ; de Sánchez N; Guhl F
Rev Latinoam Microbiol; 1991; 33(4):257-63. PubMed ID: 1670263
[TBL] [Abstract][Full Text] [Related]
10. Brain Tissue Cysts in Infected Mice with RH-Strain of Toxoplasma gondii and Evaluation of BAG1 and SAG1 Genes Expression.
Selseleh M; Modarressi M; Shojaee S; Mohebali M; Eshraghian M; Selseleh M; Keshavarz H
Iran J Parasitol; 2013 Jan; 8(1):40-6. PubMed ID: 23682258
[TBL] [Abstract][Full Text] [Related]
11. Toxoplasma gondii antigens recognized by IgG antibodies differ between mice with and without active proliferation of tachyzoites in the brain during the chronic stage of infection.
Hester J; Mullins J; Sa Q; Payne L; Mercier C; Cesbron-Delauw MF; Suzuki Y
Infect Immun; 2012 Oct; 80(10):3611-20. PubMed ID: 22851753
[TBL] [Abstract][Full Text] [Related]
12. The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8-/- mice.
Jost C; Reiter-Owona I; Liesenfeld O
Parasitol Res; 2007 Nov; 101(6):1603-9. PubMed ID: 17846793
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil.
Alves CF; Vitor RW
Parasite; 2005 Jun; 12(2):171-7. PubMed ID: 15991831
[TBL] [Abstract][Full Text] [Related]
14. Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii.
Khan AA; Lambert LH; Remington JS; Araujo FG
Antimicrob Agents Chemother; 1999 Apr; 43(4):758-62. PubMed ID: 10103177
[TBL] [Abstract][Full Text] [Related]
15. Comparative infectivity of oocysts and bradyzoites of Toxoplasma gondii for intermediate (mice) and definitive (cats) hosts.
Dubey JP
Vet Parasitol; 2006 Aug; 140(1-2):69-75. PubMed ID: 16647212
[TBL] [Abstract][Full Text] [Related]
16. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts.
Dubey JP; Lindsay DS; Speer CA
Clin Microbiol Rev; 1998 Apr; 11(2):267-99. PubMed ID: 9564564
[TBL] [Abstract][Full Text] [Related]
17. [Detection of Toxoplasma antigens and antibodies in mice infected with different strains of Toxoplasma gondii].
Lee YH; Kim KY; Kang MS; Shin DW
Korean J Parasitol; 1995 Sep; 33(3):201-10. PubMed ID: 8528627
[TBL] [Abstract][Full Text] [Related]
18. Toxoplasma gondii: detection of MIC10 antigen in sera of experimentally infected mice.
Dautu G; Ueno A; Miranda A; Mwanyumba S; Munyaka B; Carmen G; Kariya T; Omata Y; Saito A; Xuan X; Igarashi M
Exp Parasitol; 2008 Mar; 118(3):362-71. PubMed ID: 17976597
[TBL] [Abstract][Full Text] [Related]
19. Brain-tissue cysts in rats infected with the RH strain of Toxoplasma gondii.
Lecomte V; Chumpitazi BF; Pasquier B; Ambroise-Thomas P; Santoro F
Parasitol Res; 1992; 78(3):267-9. PubMed ID: 1589437
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of mice with Neospora caninum: response to oral challenge with Toxoplasma gondii oocysts.
Lindsay DS; Lenz SD; Dykstra CC; Blagburn BL; Dubey JP
J Parasitol; 1998 Apr; 84(2):311-5. PubMed ID: 9576504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
